Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 10.07.2023 · 12 (14) · 4584
DOI: 10.3390/jcm12144584 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.07.2023. Verfasst von Angelo Zinellu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Combined indices of different haematological cell types appear to be particularly promising for investigating the link between systemic inflammation and coronavirus disease 2019 (COVID-19). We conducted a systematic review and meta-analysis to assess the aggregate index of systemic inflammation (AISI), an emerging index derived from neutrophil, monocyte, platelet, and lymphocyte counts, in hospitalized COVID-19 patients with different disease severity and survival status. We searched electronic databases between the 1st of December 2019 and the 10th of June 2023 and assessed the risk of bias and the certainty of evidence. In 13 studies, severe disease/death was associated with significantly higher AISI values on admission vs. non-severe disease/survival (standard mean difference (SMD) = 0.68, 95% CI 0.38 to 0.97, p < 0.001). The AISI was also significantly associated with severe disease/death in five studies reporting odds ratios (4.39, 95% CI 2.12 to 9.06, p ˂ 0.001), but not in three studies reporting hazard ratios (HR = 1.000, 95% CI 0.999 to 1.002, p = 0.39). The pooled sensitivity, specificity, and area under the curve values for severe disease/death were 0.66 (95% CI 0.58 to 0.73), 0.78 (95% CI 0.73 to 0.83), and 0.79 (95% CI 0.76 to 0.83), respectively. Our study has shown that the AISI on admission can effectively discriminate between patients with different disease severity and survival outcome (PROSPERO registration number: CRD42023438025).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
- Anatomical Pathology and Histology, University Hospital (AOU) of Sassari, 07100 Sassari, Italy.
- Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
- Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia.
- Department of Clinical Pharmacology, Flinders Medical Centre, Southern Adelaide Local Health Network, Bedford Park, SA 5042, Australia.
ORCID-Profile: Angelo Zinellu, Panagiotis Paliogiannis, Arduino A Mangoni
Zitieren
APA
Zinellu, A., Paliogiannis, P., & Mangoni, A. A. (2023). Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 12(14), 4584. https://doi.org/10.3390/jcm12144584
Vancouver
Zinellu A, Paliogiannis P, Mangoni AA. Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2023;12(14):4584. doi:10.3390/jcm12144584
BibTeX
@article{Zinellu2023,
author = {Zinellu, Angelo and Paliogiannis, Panagiotis and Mangoni, Arduino A},
title = {Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {14},
pages = {4584},
doi = {10.3390/jcm12144584}
}
EUVIMED